Protective Effects of 5-MTP in a Rat Model of Diabetic Cardiomyopathy Through Anti-Inflammatory, Anti-Apoptotic, and Antifibrotic Mechanisms
Authors:
- Susetyo AtmojoSASusetyo Atmojo
- Bambang Budi SiswantoBSBambang Budi Siswanto
- Nurjati Chairani SiregarNSNurjati Chairani Siregar
- Aria KekalihAKAria Kekalih
- Fadlina Chany SaputriFSFadlina Chany Saputri
- Budi Susetyo PikirBPBudi Susetyo Pikir
- Deni NovianaDNDeni Noviana
- Apridya NurhafizahANApridya Nurhafizah
- Wilbert HuangWHWilbert Huang
- Puspita Eka WuyungPWPuspita Eka Wuyung
Open Access
Abstract
Background: Diabetic cardiomyopathy (DCM) is characterized by myocardial inflammation, apoptosis, and fibrosis that contribute to ventricular remodeling and dysfunction. We investigated the effects of 5-methoxytryptophan (5-MTP) on histopathological and molecular markers of myocardial remodeling in a rat model of DCM. Methods: Forty-eight Sprague–Dawley rats with DCM induced by a high-fat high-fructose diet and low-dose streptozotocin (25 mg/kg) were randomized to control or 5-MTP treatment (25, 50, or 100 mg/kg) and evaluated after 8, 16, and 32 days. Histopathological assessment using hematoxylin–eosin and Masson’s trichrome staining, along with immunohistochemical analysis of inflammatory, apoptotic, and fibrotic markers, was performed. Results: Myocardial inflammatory histopathological scores did not differ significantly among groups. Myocardial fibrosis assessed by Masson’s trichrome staining was significantly reduced at day 16 (p = 0.020), with all 5-MTP doses demonstrating lower fibrosis scores than DCM controls. Collagen I expression did not differ significantly. Caspase-3 expression was significantly reduced in all treatment groups at day 16 (p = 0.029), with persistent reduction at day 32 only in the 100 mg/kg group (p = 0.004). Early molecular modulation was observed through reduced TGF-β expression at day 8 in the 25 mg/kg and 50 mg/kg groups, followed by reduced SMAD3 expression at day 16 in the 25 mg/kg and 100 mg/kg groups. At day 16, AKT expression increased in the 25 mg/kg group, while cytoplasmic NF-κB expression decreased in the 25 mg/kg and 100 mg/kg groups. Conclusion: 5-MTP demonstrated time-dependent changes in molecular and histopathological markers associated with myocardial remodeling in experimental DCM.Keywords
Funding Information
- National Cardiovascular Center Harapan Kita
This publication has 21 references indexed in Scilit:
- A reliable strategy for establishment of an animal model of diabetic cardiomyopathy: Induction by a high-fat diet combined with single or multiple injections of low-dose streptozotocinLife Sciences, 2024
- 5-Methoxytryptophan alleviates atrial structural remodeling in ibrutinib-associated atrial fibrillationHeliyon, 2023
- Interplay between PI3K/AKT pathway and heart disordersMolecular Biology Reports, 2022
- 5-Methoxytryptophan attenuates postinfarct cardiac injury by controlling oxidative stress and immune activationJournal of Molecular and Cellular Cardiology, 2021
- Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathwayLife Sciences, 2020
- Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathyDiabetes Research and Clinical Practice, 2017
- Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy ratsCanadian Journal of Physiology and Pharmacology, 2016
- H2 and H3 relaxin inhibit high glucose-induced apoptosis in neonatal rat ventricular myocytesBiochimie, 2015
- Attenuation by Metallothionein of Early Cardiac Cell Death via Suppression of Mitochondrial Oxidative Stress Results in a Prevention of Diabetic CardiomyopathyJACC, 2006
- Nuclear Targeting of Akt Enhances Kinase Activity and Survival of CardiomyocytesCirculation Research, 2004